Dr. Jeffrey Shuren tells a U.S. House panel that the recession created a more “risk-averse” investment environment that helped push medical device companies to launch in Europe, rather than its relatively easier path to market clearance. CDRH head Dr. Jeffrey Shuren batted back several attempts by Republican lawmakers to frame the debate on medical device regulations as a question of the European system being superior to the FDA’s today during a Capitol Hill hearing.
